GlassScriptPhysician profile
Vernon E Dencklau
NPI 1821087453
$687.28
in general payments reported to CMS, 2019-2025
9 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $134 · 2021: $19.91 · 2022: $12.76 · 2023: $65.14 · 2024: $166 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $176.35 | 2019-2025 | Collagenase Santyl |
| Reprise Biomedical, INC. | $125.00 | 2025 | Miro3d |
| Kerecis Limited | $103.01 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Urgo Medical North America, LLC | $86.23 | 2024 | Urgok2 |
| Next Science LLC | $65.14 | 2023 | Surgx, Blastx, Xperience |
| Kci USA, INC. | $53.17 | 2020-2021 | |
| Misonix INC | $47.84 | 2020 | |
| Convatec INC. | $17.78 | 2020 | |
| Hydrofera LLC | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vernon Dencklau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.